| Revenue | NOK 0 | — |
| EBITDA | NOK -7K | +96% |
| Net profit | NOK -7K | +99% |
| Total assets | NOK 509K | -1% |
| Equity | NOK 509K | -1% |
| Employees | 0 | — |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −908 | −127 | −0 |
| EBITDA | −3 | −1 193 | −204 | −7 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −3 | −1 193 | −204 | −7 |
| Net financials | 0 | −7 650 | −420 | 0 |
| Profit before tax | −3 | −8 844 | −623 | −7 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −3 | −8 844 | −623 | −7 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5 083 | 1 302 | 516 | 509 |
| Equity | 4 983 | 1 139 | 516 | 509 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 100 | 163 | 0 | 0 |
| Total debt | 100 | 163 | 0 | 0 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fam Vekst As | Company | 40.0% | 40.0% | 2022 |
Apache As | Company | 20.0% | 20.0% | 2022 |
Focus Pharma As | Company | 20.0% | 20.0% | 2022 |
Trida As | Company | 20.0% | 20.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Ståle Kolbjørn Angel | Board of Directors | 0 companies |
| Erik Frydenberg | Chairman | 0 companies |
| Camilla Tunold | Board of Directors | 0 companies |
| Ida Margrethe Perez | Board of Directors | 0 companies |
| Trond Karlsen | Chairman | 0 companies |
| Bjørn Erik Bergseng | Board of Directors | 0 companies |
| Christer Bøckman Tunold | Board of Directors | 0 companies |